DDDorothea Dijkstra

Dorothea Dijkstra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dorothea Dijkstra has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Fiona C. Shenton

    Centre for Integrative Neuroscience, Durham University, School of Biological and Biomedical Sciences, Durham, UK

    2 shared publications
  • Holger Stark

    Institute of Pharmaceutical and Medicinal Chemistry Heinrich Heine University Düsseldorf Duesseldorf Germany

    2 shared publications
  • Jens Michael Hohlfeld

    Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL) Hannover Germany

    2 shared publications
  • Ralf Gutzmer

    Department of Dermatology and Allergology, Hannover Medical School, Hannover, Germany

    2 shared publications
  • Rob Leurs

    Department of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

    2 shared publications
  • Thomas Werfel

    Department of Dermatology and Allergology, Hannover Medical School, Hannover, Germany

    2 shared publications

Latest Publications

  • Open Access

    Effects of ultrafine particles on the allergic inflammation in the lung of asthmatics: results of a double-blinded randomized cross-over clinical pilot study

    by Frank Schaumann, Cornelia Frömke, Dorothea Dijkstra, Francesca Alessandrini, Horst Windt, Erwin Karg, Meike Müller, Carla Winkler, Armin Braun, Armin Koch, et al.

    Epidemiological and experimental studies suggest that exposure to ultrafine particles (UFP) might aggravate the allergic inflammation of the lung in asthmatics. We exposed 12 allergic asthmatics in two subgroups in a double-blinded randomized cross-over design, first to freshly generated ultrafine carbon particles (64 μg/m3; 6.1 ± 0.4 × 105 particles/cm3 for 2 h) and then to filtered air or vice versa with a 28-day recovery period in-between. Eighteen hours after each exposure, grass pollen was instilled into a lung lobe via bronchoscopy. Another 24 hours later, inflammatory cells were collected by means of bronchoalveolar lavage (BAL). (Trial registration: NCT00527462) For the entire study group, inhalation of UFP by itself had no significant effect on the allergen induced inflammatory response measured with total cell count as compared to exposure with filtered air (p = 0.188). However, the subgroup of subjects, which inhaled UFP during the first exposure, exhibited a significant increase in total BAL cells (p = 0.021), eosinophils (p = 0.031) and monocytes (p = 0.013) after filtered air exposure and subsequent allergen challenge 28 days later. Additionally, the potential of BAL cells to generate oxidant radicals was significantly elevated at that time point. The subgroup that was exposed first to filtered air and 28 days later to UFP did not reveal differences between sessions. Our data demonstrate that pre-allergen exposure to UFP had no acute effect on the allergic inflammation. However, the subgroup analysis lead to the speculation that inhaled UFP particles might have a long-term effect on the inflammatory course in asthmatic patients. This should be reconfirmed in further studies with an appropriate study design and sufficient number of subjects.


  • Open Access

    Identification and quantification of basophils in the airways of asthmatics following segmental allergen challenge

    by Dorothea Dijkstra, Christian Hennig, Gesine Hansen, Heike Biller, Norbert Krug, Jens M. Hohlfeld

    During asthma attacks, allergens activate sensitized basophils in the lung, thereby aggravating symptoms. Due to the paucity of basophils in bronchial lavage fluid and the lack of specific basophil detection and quantification methods, basophil‐directed research in these samples was hampered in the past. This study aimed to establish and validate a flow cytometry‐based basophil detection and quantification method for human basophils from bronchoalveolar lavage (BAL) and blood as a prerequisite for a better understanding of their pathogenic contribution and subtyping of asthma phenotypes. BAL and blood leukocytes from seasonal asthmatics were analyzed by flow cytometry. Chipcytometry, a highly sensitive single‐cell analysis method, was used to validate the staining panel for basophils. Cell differentials of May–Grünwald–Giemsa‐stained cytospins were used to compare basophil percentages. BAL basophils are identifiable as CD123+HLA‐DR−CD3−CD14−CD19−CD20−CD56− cells in flow cytometrical analysis. Their identity was validated by Chipcytometry. CD203c was highly expressed by BAL basophils, whereas it was expressed at variable levels on blood basophils. The two quantification methods correlated, although more basophils were detected by flow cytometry. Furthermore, the increase in basophil percentages in the lung correlated with the decrease in the basophil percentages in the blood after allergen challenge. We here validated a reliable basophil quantification method, which is independent of the cell's activation and degranulation state. The results obtained with this method indicate that basophils are directly recruited from the blood circulation to the airway lumen. © 2014 International Society for Advancement of Cytometry


  • Open Access

    Human Inflammatory Dendritic Epidermal Cells Express a Functional Histamine H4 Receptor

    by Dorothea Dijkstra, Holger Stark, Paul L. Chazot, Fiona C. Shenton, Rob Leurs, Thomas Werfel, Ralf Gutzmer


  • Histamine downregulates monocyte CCL2 production through the histamine H4 receptor

    by Dorothea Dijkstra, Rob Leurs, Paul Chazot, Fiona C. Shenton, Holger Stark, Thomas Werfel, Ralf Gutzmer